0001485003-17-000070.txt : 20170523
0001485003-17-000070.hdr.sgml : 20170523
20170523164752
ACCESSION NUMBER: 0001485003-17-000070
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170519
FILED AS OF DATE: 20170523
DATE AS OF CHANGE: 20170523
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001485003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262025616
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-444-8550
MAIL ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CHANEY PAUL G
CENTRAL INDEX KEY: 0001277477
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36296
FILM NUMBER: 17864342
MAIL ADDRESS:
STREET 1: 3 TIMES SQUARE, 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
wf-form4_149557245721975.xml
FORM 4
X0306
4
2017-05-19
0
0001485003
Eleven Biotherapeutics, Inc.
EBIO
0001277477
CHANEY PAUL G
C/O ELEVEN BIOTHERAPEUTICS, INC.
245 FIRST STREET, SUITE 1800
CAMBRIDGE
MA
02142
1
0
0
0
Stock Option
1.48
2017-05-19
4
A
0
8072
0
A
2027-05-18
Common Stock
8072.0
8072
D
The option was granted on May 19, 2017 and vests over one year, with 1/12th of the shares subject to the option vesting at the end of each successive one-month period following the grant date until the earlier of a) the day that is one business day prior to the date of the next annual meeting and b) the first anniversary of the grant date, at which time such option shall be fully vested.
/s/ John J. McCabe as attorney-in-fact
2017-05-23